(VRML:Consolidated Issue listed on NASDAQ Capital Market)
Daniel W. Chan Ph.D., DABCC, FACR
Member of Scientific Advisory Board, Vermillion, Inc.
|Age||Total Calculated Compensation||This person is connected to 24 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Dr. Daniel W. Chan PhD, DABCC, FACB is Professor of Pathology, Oncology, Urology and Radiology, Director of Clinical Chemistry Division, Department of Pathology, and the Director, Center for Biomarker Discovery at the Johns Hopkins University School of Medicine. Dr. Chan serves as the Co-Principal Investigator of JHU Prostate Cancer. Responsibilities including the heading of hospital clinical chemistry laboratory, he conducts cutting edge research using state of the ...
Building IIIPhone: 512-519-0400
Austin, Texas 78738
Board Members Memberships*There is no Board Members Memberships data available.
University at Buffalo
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Gon-Emon Kurihara||President and Representative Director|
|Russell Cummings||Chief Executive Officer, Executive Director and Member of Investment Committee|
Imperial Innovations Group plc
|Christopher J. Moreau||Chief Executive Officer, President and Non Independent Director|
|Rene A. Schena||Chairman and Chief Executive Officer|
|Jan Groen Ph.D.||Chief Executive Officer, President and Executive Director|
|€491.1K||Compensation as of Fiscal Year --.|